theophylline intranasal (CYR-064)
/ Cyrano Therapeutics, Kyorin
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
February 19, 2026
Study of CYR-064 Versus Placebo in Patients.
(clinicaltrials.gov)
- P2 | N=151 | Completed | Sponsor: Cyrano Therapeutics, Inc. | Active, not recruiting ➔ Completed
Trial completion
1 to 1
Of
1
Go to page
1